Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs

BACKGROUND: The durability of off-treatment virologic responses has not been fully elucidated in chronic hepatitis B (CHB) patients who have previously achieved complete virologic suppression with nucleos(t)ide analog (NA) therapy. This study aimed to assess off-treatment virologic relapse rates and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Hyung Rae, Min, Bo Young, Song, Joon Chang, Seong, Mun Hyuk, Lee, Sang Soo, Jang, Eun Sun, Shin, Cheol Min, Park, Young Soo, Hwang, Jin-Hyeok, Jeong, Sook-Hyang, Kim, Nayoung, Lee, Dong Ho, Kim, Jin-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148928/
https://www.ncbi.nlm.nih.gov/pubmed/25125320
http://dx.doi.org/10.1186/1471-2334-14-439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148928/
https://www.ncbi.nlm.nih.gov/pubmed/25125320
http://dx.doi.org/10.1186/1471-2334-14-439

Ejemplares similares